Merck & Company Inc (MRK) Insider Trading
- $76,196,930.25
- $746,098,067.04
- Feb. 9, 2026
- Kenneth C Frazier
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 9, 2026 | EVP | 121,573 | $119.15 | Sell | $14,485,422.95 | |
| Feb. 9, 2026 | CMO | 10,000 | $118.41 | Sell | $1,184,100.00 | |
| Feb. 6, 2026 | Insider | 15,000 | $121.87 | Sell | $1,828,050.00 | |
| Feb. 6, 2026 | EVP | 37,685 | $120.92 | Sell | $4,556,870.20 | |
| Feb. 6, 2026 | EVP | 5,000 | $121.91 | Sell | $609,550.00 | |
| Feb. 5, 2026 | CMO | 20,000 | $121.88 | Sell | $2,437,600.00 | |
| Feb. 4, 2026 | CEO | 47,434 | $118.04 | Sell | $5,599,109.36 | |
| Feb. 4, 2026 | CFO | 41,997 | $119.61 | Sell | $5,023,261.17 | |
| Feb. 4, 2026 | VP | 15,087 | $118.77 | Sell | $1,791,882.99 | |
| Feb. 4, 2026 | SVP | 6,400 | $119.67 | Sell | $765,888.00 | |
| May 5, 2025 | U.S. Congress Member <small>(R-GA)</small> | 0 | $82.85 | Buy | $0.00 | |
| April 25, 2025 | SVP | 4,262 | $82.76 | Sell | $352,723.12 | |
| April 9, 2025 | U.S. Congress Member <small>(R-GA)</small> | 0 | $81.82 | Buy | $0.00 | |
| Feb. 6, 2025 | Insider | 2,361 | $88.76 | Sell | $209,562.36 | |
| Feb. 6, 2025 | Director | 2,833 | $88.25 | Buy | $250,012.25 | |
| Sept. 4, 2024 | U.S. Congress Member <small>(R-MI)</small> | 0 | $115.80 | Sell | $0.00 | |
| Feb. 13, 2024 | Insider | 1,000 | $124.89 | Sell | $124,890.00 | |
| Feb. 2, 2024 | EVP | 50,694 | $126.65 | Sell | $6,420,395.10 | |
| Nov. 9, 2023 | Insider | 2,081 | $102.38 | Sell | $213,052.78 | |
| Nov. 8, 2023 | EVP | 43,823 | $105.03 | Sell | $4,602,729.69 | |
| Aug. 14, 2023 | EVP | 4,250 | $109.01 | Sell | $463,292.50 | |
| Aug. 3, 2023 | EVP | 4,500 | $105.49 | Sell | $474,705.00 | |
| May 4, 2023 | VP | 15,875 | $117.53 | Sell | $1,865,788.75 | |
| May 3, 2023 | EVP | 53,400 | $119.01 | Sell | $6,355,134.00 | |
| May 1, 2023 | EVP | 75,436 | $116.03 | Sell | $8,752,839.08 | |
| April 28, 2023 | CEO | 143,329 | $114.93 | Sell | $16,472,801.97 | |
| April 28, 2023 | EVP | 66,163 | $115.00 | Sell | $7,608,745.00 | |
| April 13, 2023 | insider | 134,055 | $115.07 | Sell | $15,425,708.85 | |
| Feb. 15, 2023 | Insider | 5,000 | $108.22 | Sell | $541,100.00 | |
| Feb. 13, 2023 | EVP | 1,815 | $109.10 | Sell | $198,016.50 | |
| Feb. 9, 2023 | EVP | 5,000 | $107.00 | Sell | $535,000.00 | |
| Feb. 6, 2023 | EVP | 4,436 | $104.25 | Sell | $462,453.00 | |
| Jan. 9, 2023 | Insider | 83,994 | $112.29 | Sell | $9,431,686.26 | |
| Nov. 10, 2022 | EVP | 15,000 | $101.42 | Sell | $1,521,300.00 | |
| Nov. 9, 2022 | CEO | 167,613 | $102.44 | Sell | $17,170,275.72 | |
| Nov. 9, 2022 | Insider | 1,795 | $103.21 | Sell | $185,261.95 | |
| Nov. 8, 2022 | EVP | 20,000 | $101.00 | Sell | $2,020,000.00 | |
| Nov. 7, 2022 | Insider | 45,561 | $99.47 | Sell | $4,531,952.67 | |
| Nov. 4, 2022 | Insider | 235,000 | $98.61 | Sell | $23,173,350.00 | |
| Oct. 31, 2022 | Insider | 300,000 | $100.75 | Sell | $30,225,000.00 | |
| Oct. 28, 2022 | Insider | 100,292 | $100.10 | Sell | $10,039,229.20 | |
| Oct. 28, 2022 | VP | 31,997 | $100.34 | Sell | $3,210,578.98 | |
| Oct. 28, 2022 | EVP | 164,557 | $100.26 | Sell | $16,498,484.82 | |
| Nov. 9, 2021 | Insider | 663,881 | $82.26 | Sell | $54,610,851.06 | |
| Nov. 4, 2021 | EVP | 29,782 | $90.40 | Sell | $2,692,292.80 | |
| Nov. 4, 2021 | CFO | 18,335 | $91.00 | Sell | $1,668,485.00 | |
| Nov. 3, 2021 | VP | 25,000 | $88.45 | Sell | $2,211,250.00 | |
| Nov. 1, 2021 | EVP | 39,762 | $87.87 | Sell | $3,493,886.94 | |
| Oct. 29, 2021 | Insider | 24,619 | $87.32 | Sell | $2,149,731.08 | |
| Oct. 29, 2021 | EVP | 135,405 | $87.56 | Sell | $11,856,061.80 |
Insiders are both buying and selling Merck & Company Inc stock.
The insider traders at Merck & Company Inc are: Kenneth C Frazier, Richard R Deluca, Adam H Schechter, Steven Mizell, Sanat Chattopadhyay, Robert M Davis, Weir Mirian M Graddick, Wendell P Weeks, Julie L Gerberding, Frank Clyburn, Rita A Karachun, Johannes Jacobus Oosthuizen, Willie A Deese, Bruce N Kuhlik, Clark Golestani, Rochelle B Lazarus, Caroline Litchfield, Marjorie Taylor Greene, Merck & Co., Inc., Michael J Holston, Chirfi Guindo, Adele D Ambrose, Kenneth Frazier, Adam Schechter, Thomas H Glocer, Joseph Romanelli, Dalton E Smart III, Willie Deese, Michael J. Holston, Adele D. Ambrose, Ashley Watson, Bridgette Heller, Bridgette P Heller, Bruce Kuhlik, Cristal N Downing, C Robert Kidder, David Michael Williams, Dean Y Li, Inge G Thulin, Jennifer Zachary, John Canan, John James, Julie L. Gerberding, Kenneth C. Frazier, Leslie A Brun, Patricia F Russo, Peter C Wendell, Peter C. Wendell, Peter Wendell, Rita A. Karachun, Roger M Perlmutter, Thomas R Cech, Weir Mirian M. Graddick, and Wendell P. Weeks
The most active insider trader at Merck & Company Inc is Kenneth C Frazier with 26 trades.
Kenneth C Frazier has sold the most Merck & Company Inc stock with a total value of $294,584,131.58.
Merck & Co., Inc. has bought the most Merck & Company Inc stock with a total value of $141,893,846.00.
The most recent insider trade for Merck & Company Inc was on Feb. 9, 2026.
The single biggest insider buy for Merck & Company Inc was from Merck & Co., Inc. with a total value of $65,946,928.00 on April 8, 2019.
The single biggest insider sell for Merck & Company Inc was from Kenneth C Frazier with a total value of $54,610,851.06 on Nov. 9, 2021.